Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids
- 1 August 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (8) , 1461-1468
- https://doi.org/10.1021/jm00158a024
Abstract
Note: In lieu of an abstract, this is the article's first page.This publication has 24 references indexed in Scilit:
- Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.Proceedings of the National Academy of Sciences, 1977
- Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterizationProstaglandins, 1977
- Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.Proceedings of the National Academy of Sciences, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977
- Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane systhetaseBiochemical and Biophysical Research Communications, 1977
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature, 1976
- THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOODBritish Journal of Pharmacology and Chemotherapy, 1964
- Tryptamine receptorsThe Journal of Physiology, 1953